Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Filings indexed 1,585 across all filing types
Latest filing 2019-10-15 Director's Dealing
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2019-10-15 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Natera, Inc. dated October 10, 2019. It announces an upcoming investor call and provides an investor presentation as an exhibit. The text explicitly states that the investor presentation is furnished as Exhibit 99.1 and is incorporated by reference. The document does not contain detailed financial statements or substantive financial data itself but rather serves as a disclosure of the event and the presentation. The length of the document is 4018 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, announcements of presentations or reports that are short and refer to attached exhibits should be classified as Regulatory Filings (RNS) rather than the report type itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-10-10 English
4 Filing
Director's Dealing
2019-10-02 English
4 Filing
Director's Dealing
2019-10-01 English
4 Filing
Director's Dealing
2019-09-24 English
4 Filing
Director's Dealing
2019-09-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.